XML 12 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Earnings - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Feb. 28, 2026
Nov. 30, 2025
Aug. 31, 2025
Feb. 28, 2025
Nov. 30, 2024
Aug. 31, 2024
Feb. 28, 2026
Feb. 28, 2025
May 31, 2025
Income Statement [Abstract]                  
Net sales $ 769.8     $ 687.4     $ 2,514.6 $ 2,260.4  
Cost of goods sold 693.7     606.2     2,230.1 1,998.8  
Gross margin 76.1     81.2     284.5 261.6  
Selling, general and administrative expense 77.5     54.6     216.3 172.7  
Impairment of assets 1.5 $ 0.6   7.4     2.1 7.4  
Restructuring and other (income),) expense, net (6.0)     0.9     (7.0) 0.9  
Operating income 3.1     18.3     73.1 80.6  
Other income (expense):                  
Miscellaneous income (expense), net 9.8     0.2     9.9 (1.9)  
Interest expense, net (2.1)     (1.4)     (7.7) (6.1)  
Equity in net income of unconsolidated affiliate 3.5     0.0     16.7 0.4  
Earnings before income taxes 14.3     17.1     92.0 73.0  
Income tax expense 3.5     5.0     21.1 12.6  
Net earnings 10.8     12.1 $ 16.1 $ 32.2 70.9 60.4  
Net earnings (loss) attributable to noncontrolling interests 0.4     (1.7)     4.9 5.4  
Net earnings attributable to controlling interest $ 10.4     $ 13.8     $ 66.0 $ 55.0  
Basic                  
Weighted average common shares outstanding 49,900,000     49,500,000     49,800,000 49,500,000  
Earnings per share attributable to controlling interest $ 0.21     $ 0.28     $ 1.33 $ 1.11  
Diluted                  
Weighted average common shares outstanding 50,900,000     50,500,000     50,700,000 50,500,000  
Earnings per share attributable to controlling interest $ 0.2     $ 0.27     $ 1.3 $ 1.09  
Common shares outstanding at end of period 49,910,958     49,500,000     49,910,958 49,500,000 49,548,895
Cash dividends declared per share $ 0.16 $ 0.16 $ 0.16 $ 0.16 $ 0.16 $ 0.16 $ 0.48 $ 0.48